Selligence

Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary

Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary

09/02/2023, 12:46AM

Related Article

  • logo

    biotech-365.com

    Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary

    article